Jade Biosciences, Inc. Cash
Jade Biosciences, Inc. (JBIO) had Cash of $1.60 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Assets › Cash and Cash Equivalent
us-gaap:Cash · last filed 2022-03-30
- 2021-09-30: Cash $1.60M.
- 2021-06-30: Cash $1.40M.
- 2020-12-31: Cash $4.60M.
| Period end | Cash |
|---|---|
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.40M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $4.60M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |